SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-014790
Filing Date
2023-11-03
Accepted
2023-11-03 20:14:12
Documents
2
Period of Report
2023-10-24

Document Format Files

Seq Description Document Type Size
1 form3-11042023_121106.html 3  
1 form3-11042023_121106.xml 3 5559
2 ex24-11042023_121107.htm EX-24 6691
  Complete submission text file 0001415889-23-014790.txt   13826
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Prince Joshua S. (Reporting) CIK: 0001998663 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37761 | Film No.: 231377867